Harbour Investments’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20K Sell
1,370
-630
-32% -$6.08K ﹤0.01% 2949
2026
Q1
$14.8K Buy
2,000
+240
+14% +$2.52K ﹤0.01% 3059
2025
Q4
$20.7K Sell
1,760
-635
-27% -$6.85K ﹤0.01% 2400
2025
Q3
$18.5K Sell
2,395
-440
-16% -$3.08K ﹤0.01% 2388
2025
Q2
$20.7K Hold
2,835
﹤0.01% 2216
2025
Q1
$26.9K Sell
2,835
-2,937
-51% -$36.7K ﹤0.01% 2059
2024
Q4
$95.1K Sell
5,772
-920
-14% -$14.3K ﹤0.01% 1380
2024
Q3
$98.7K Sell
6,692
-250
-4% -$3.91K ﹤0.01% 1323
2024
Q2
$96.3K Hold
6,942
﹤0.01% 1263
2024
Q1
$109K Sell
6,942
-579
-8% -$8.94K ﹤0.01% 1172
2023
Q4
$122K Hold
7,521
0.01% 1063
2023
Q3
$92.5K Sell
7,521
-790
-10% -$11.7K ﹤0.01% 1080
2023
Q2
$134K Sell
8,311
-253
-3% -$4.17K 0.01% 940
2023
Q1
$149K Sell
8,564
-250
-3% -$3.56K 0.01% 878
2022
Q4
$81.4K Sell
8,814
-1,060
-11% -$9.88K 0.01% 1103
2022
Q3
$80K Hold
9,874
0.01% 1073
2022
Q2
$80K Buy
+9,874
New +$94.3K 0.01% 1073
2021
Q4
$407K Sell
11,934
-4,300
-26% -$168K 0.02% 479
2021
Q3
$783K Sell
16,234
-122
-0.7% -$5.65K 0.03% 504
2021
Q2
$739K Buy
16,356
+510
+3% +$22.6K 0.02% 531
2021
Q1
$764K Buy
+15,846
New +$825K 0.03% 470

Other funds holding NEO

Harbour Investments's NEO Position: Q2 2026 in Review

Harbour Investments reduced its NeoGenomics (NEO) stake by 32% in Q2 2026, selling an estimated $6.08K and leaving 1,370 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #2949.

Harbour Investments first reported a position in NEO in Q1 2021 and has held it in 21 quarters since. The position peaked at $783K in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Harbour Investments held 1,370 shares of NeoGenomics worth $20K as of Q2 2026.
  • Harbour Investments sold 630 NeoGenomics shares in Q2 2026, an estimated $6.08K.
  • NeoGenomics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2949 holding.
  • Harbour Investments first reported a position in NeoGenomics in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's NeoGenomics position peaked at $783K in Q3 2021.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.